- Home
- TENB vs ALVO Comparison
TENB vs ALVO Comparison
Compare TENB & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENB
- ALVO
- Stock Information
- Founded
- TENB 2002
- ALVO 2013
- Country
- TENB United States
- ALVO Luxembourg
- Employees
- TENB N/A
- ALVO N/A
- Industry
- TENB Computer Software: Prepackaged Software
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- TENB Technology
- ALVO Health Care
- Exchange
- TENB Nasdaq
- ALVO Nasdaq
- Market Cap
- TENB 4.9B
- ALVO 4.0B
- IPO Year
- TENB 2018
- ALVO N/A
- Fundamental
- Price
- TENB $41.06
- ALVO $13.36
- Analyst Decision
- TENB Buy
- ALVO Buy
- Analyst Count
- TENB 17
- ALVO 1
- Target Price
- TENB $50.13
- ALVO $18.00
- AVG Volume (30 Days)
- TENB 890.2K
- ALVO 184.6K
- Earning Date
- TENB 02-05-2025
- ALVO 11-13-2024
- Dividend Yield
- TENB N/A
- ALVO N/A
- EPS Growth
- TENB N/A
- ALVO N/A
- EPS
- TENB N/A
- ALVO N/A
- Revenue
- TENB $877,596,000.00
- ALVO $393,919,000.00
- Revenue This Year
- TENB $14.43
- ALVO $398.12
- Revenue Next Year
- TENB $9.64
- ALVO $44.73
- P/E Ratio
- TENB N/A
- ALVO N/A
- Revenue Growth
- TENB 13.97
- ALVO 517.92
- 52 Week Low
- TENB $35.25
- ALVO $9.15
- 52 Week High
- TENB $53.50
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- TENB 53.06
- ALVO 64.20
- Support Level
- TENB $37.78
- ALVO $13.06
- Resistance Level
- TENB $43.36
- ALVO $13.50
- Average True Range (ATR)
- TENB 1.20
- ALVO 0.37
- MACD
- TENB 0.29
- ALVO -0.00
- Stochastic Oscillator
- TENB 58.78
- ALVO 69.09
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.